Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $4.3 million.

  • Onconetix's Cash from Financing Activities rose 64158.85% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year increase of 6926.94%. This contributed to the annual value of $6.7 million for FY2024, which is 55147.04% up from last year.
  • Latest data reveals that Onconetix reported Cash from Financing Activities of $4.3 million as of Q3 2025, which was up 64158.85% from $744574.0 recorded in Q2 2025.
  • Onconetix's Cash from Financing Activities' 5-year high stood at $5.2 million during Q1 2024, with a 5-year trough of -$343426.0 in Q2 2024.
  • For the 3-year period, Onconetix's Cash from Financing Activities averaged around $1.6 million, with its median value being $1.0 million (2023).
  • Data for Onconetix's Cash from Financing Activities shows a peak YoY increase of 1073262.04% (in 2024) and a maximum YoY decrease of 5998.53% (in 2024) over the last 5 years.
  • Over the past 3 years, Onconetix's Cash from Financing Activities (Quarter) stood at $1.3 million in 2023, then rose by 0.32% to $1.3 million in 2024, then surged by 229.38% to $4.3 million in 2025.
  • Its Cash from Financing Activities stands at $4.3 million for Q3 2025, versus $744574.0 for Q2 2025 and $2.9 million for Q1 2025.